Cidara Thera (CDTX)

$1.16 0.27 (18.88%)

16:00 EDT CDTX Stock Quote Delayed 30 Minutes

Why Is Cidara Therapeutics (CDTX) Stock Down 12% Today?

By William White, InvestorPlace Writer Mar 23, 2023

Cidara Therapeutics (CDTX) stock is falling on Thursday despite the immunotherapy company getting positive news from the FDA.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles

Volume:

Previous Close -

Market Cap 57.43M

PE Ratio -4.00

EPS -0.29

Volume (Avg. Vol.) 8.22M

Day's Range $1.13 - $1.43

52-Week Range $0.40 - $2.10

Dividend & Yield N/A (N/A)

CDTX Stock Predictions, Articles, and Cidara Thera News

From InvestorPlace
From the Web

6 Cheap Stocks to Buy Under $7

By Maya Sasson, Writer, TipRanks Jan 15, 2020

No matter what, investors are always after returns. These six cheap stocks can make those returns a reality in 2020.

7 Stocks the Insiders Are Buying on Sale

By Mark Putrino, CMT Oct 1, 2019

Insiders sell stocks for many reasons, but the only reason they buy is that they believe they will profit. Check out these insider buying picks.

Biggest Movers in Manufacturing Stocks Now – VCEL AUPH ONVO CC

By Portfolio Grader Dec 13, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 12, 2016

This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

40 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 5, 2016

The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Hottest Manufacturing Stocks Now – LPCN AXGN RETA CHRS

By Portfolio Grader Oct 7, 2016

The following stocks were moving the Manufacturing sector today.

Hottest Manufacturing Stocks Now – SSNI INNL VBLT SPHS

By Portfolio Grader Jun 30, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX

By Portfolio Grader Jun 17, 2016

The following stocks were moving the Manufacturing sector today.

19 Biotechnology Stocks to Sell Now

By Portfolio Grader May 23, 2016

This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Cidara stock falls amid selloff in antifungal space (NASDAQ:CDTX)

From Seeking Alpha Mar 23, 2023

Despite strong gains early this week, antifungal drug developers sold off on Thursday even after FDA nod for Cidara's (CDTX) candidemia drug Rezzayo. Read more here.

Cidara stock dips despite FDA approval of antifungal drug Rezzayo

From Seeking Alpha Mar 23, 2023

The U.S. Food and Drug Administration (FDA) approved Cidara Therapeutics (CDTX) and Melinta Therapeutics' Rezzayo (rezafungin for injection) to treat candidemia and invasive candidiasis...

CDTX stock extends gains ahead of FDA decision on antifungal therapy (NASDAQ:CDTX)

From Seeking Alpha Mar 22, 2023

After reaching a 52-week high yesterday, Cidara Therapeutics (CDTX) continued to gain on Wednesday as it awaits the FDA decision on antifungal therapy rezafungin. Read the full story ehre.

Cidara Therapeutics adds 31% on mid-stage data of flu prophylactic drug (NASDAQ:CDTX)

From Seeking Alpha Mar 1, 2023

Cidara Therapeutics (CDTX) closed up 31% on Wednesday, boosted by positive interim results from a mid-stage trial on CD388, its prophylactic drug candidate for influenza.Results on...

Cidara stock pops as CD388 helps cut influenza risk in phase 2a trial (NASDAQ:CDTX)

From Seeking Alpha Mar 1, 2023

Cidara Therapeutics (CDTX) said interim data from an ongoing Phase 2a trial showed that a single dose of CD388 decreased influenza viral replication in the upper respiratory tract...

H.C. Wainwright Keeps Their Buy Rating on Cidara Therapeutics (CDTX)

From TipRanks Dec 2, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Cidara Therapeutics (CDTX – Research Report), with a price targ...